WTA
GILD icon

Washington Trust Advisors’s Gilead Sciences GILD Stock Holding History

Washington Trust Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$89.1K Sell
705
-254
-26% -$33.5K 0.01% 305
2026
Q1 		$134K Hold
959
– – 0.01% 261
2025
Q4 		$118K Sell
959
-90
-9% -$10.9K 0.01% 270
2025
Q3 		$116K Buy
1,049
+449
+75% +$51K 0.01% 267
2025
Q2 		$66.5K Hold
600
– – 0.01% 299
2025
Q1 		$67.2K Sell
600
-50
-8% -$5.16K 0.01% 292
2024
Q4 		$60K Sell
650
-19
-3% -$1.71K 0.01% 307
2024
Q3 		$56.1K Sell
669
-100
-13% -$7.63K ﹤0.01% 309
2024
Q2 		$52.8K Sell
769
-107
-12% -$7.14K ﹤0.01% 313
2024
Q1 		$64.2K Hold
876
– – 0.01% 286
2023
Q4 		$71K Buy
876
+11
+1% +$856 0.01% 276
2023
Q3 		$64.8K Buy
865
+58
+7% +$4.46K 0.01% 274
2023
Q2 		$62.2K Sell
807
-238
-23% -$19K 0.01% 274
2023
Q1 		$86.7K Sell
1,045
-26
-2% -$2.15K 0.01% 256
2022
Q4 		$91.9K Sell
1,071
-12
-1% -$950 0.01% 263
2022
Q3 		$67K Buy
1,083
+37
+4% +$2.33K 0.01% 342
2022
Q2 		$65K Sell
1,046
-320
-23% -$19.8K 0.01% 359
2022
Q1 		$81K Sell
1,366
-19
-1% -$1.22K 0.01% 367
2021
Q4 		$101K Buy
+1,385
New +$95.4K 0.01% 364

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Washington Trust Advisors's GILD Position: Q2 2026 in Review

Washington Trust Advisors reduced its Gilead Sciences (GILD) stake by 26% in Q2 2026, selling an estimated $33.5K and leaving 705 shares worth $89.1K. The position accounts for 0.01% of the portfolio, ranked #305.

Washington Trust Advisors first reported a position in GILD in Q4 2021 and has held it in 19 quarters since. The position peaked at $134K in Q1 2026. 2,291 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Washington Trust Advisors held 705 shares of Gilead Sciences worth $89.1K as of Q2 2026.
  • Washington Trust Advisors sold 254 Gilead Sciences shares in Q2 2026, an estimated $33.5K.
  • Gilead Sciences made up 0.01% of Washington Trust Advisors's portfolio in Q2 2026, its #305 holding.
  • Washington Trust Advisors first reported a position in Gilead Sciences in Q4 2021 and has held it in 19 quarters since.
  • Washington Trust Advisors's Gilead Sciences position peaked at $134K in Q1 2026.
  • 2,291 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Washington Trust Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.